Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): Results of an open‐label randomized controlled trial

Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature

(2022) Himanshu Pruthi et al.   MYCOPATHOLOGIA

Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India

(2022) Valliappan Muthu et al.   LANCET INFECTIOUS DISEASES

P397 Influence of underlying conditions on disease presentation and diagnostic strategy during pulmonary mucormycosis: Anational study of 114 cases

(2022) Anne Coste et al.   MEDICAL MYCOLOGY

Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature

(2022) Vikram Damaraju et al.   MYCOSES

Scedosporium apiospermum and Lichtheimia corymbifera Co-Infection Due to Inhalation of Biogas in Immunocompetent Patients: A Case Series

(2022) Yu Song et al.   Infection and Drug Resistance

Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis

(2021) Valliappan Muthu et al.   CLINICAL MICROBIOLOGY AND INFECTION

Role of flexible bronchoscopy in the diagnosis of invasive fungal infections

(2021) Valliappan Muthu et al.   MYCOSES

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances

(2021) Aaron M. Orkin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries

(2021) Shivaprakash M. Rudramurthy et al.   MYCOSES

Nebulised liposomal-amphotericin-B as maintenance therapy in ABPA: a randomised, multicentre, trial

(2021) Cendrine Godet et al.   EUROPEAN RESPIRATORY JOURNAL

Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies

(2020) Ceyhan Ceran Serdar et al.   Biochemia Medica

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

(2019) J Peter Donnelly et al.   CLINICAL INFECTIOUS DISEASES

A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India

(2019) A. Patel et al.   CLINICAL MICROBIOLOGY AND INFECTION

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

(2019) Oliver A Cornely et al.   LANCET INFECTIOUS DISEASES

A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis

(2016) Babu Ram et al.   JOURNAL OF ASTHMA

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

(2016) Johan A Maertens et al.   LANCET

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

(2016) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials

(2013) Kenneth F. Schulz   ANNALS OF INTERNAL MEDICINE

Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis

(2013) Tomo Mihara et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients

(2013) Harutai Kamalaporn et al.   PEDIATRIC PULMONOLOGY

Deferasirox in mucormycosis: hopefully, not defeated

(2011) R. Soman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial

(2011) Brad Spellberg et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitrocharacterization of nebulizer delivery of liposomal amphotericin B aerosols

(2011) Barbara D. Alexander et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety

(2009) Víctor Monforte et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial

(2008) Bart J. Rijnders et al.   CLINICAL INFECTIOUS DISEASES